alpha-methylhistamine has been researched along with Migraine Disorders in 1 studies
alpha-methylhistamine: a histamine H3 receptor agonist; RN given refers to parent cpd without isomeric designation
alpha-methylhistamine : An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millán-Guerrero, RO | 1 |
| Pineda-Lucatero, AG | 1 |
| Hernández-Benjamín, T | 1 |
| Tene, CE | 1 |
| Pacheco, MF | 1 |
1 trial available for alpha-methylhistamine and Migraine Disorders
| Article | Year |
|---|---|
Nalpha-methylhistamine safety and efficacy in migraine prophylaxis: phase I and phase II studies.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Hi | 2003 |